Serious money on the table early this morning! 7,6
Post# of 376
PPCH is on the veryge of Phase I human trials for cancer with their lead product PRP that has shown a high degree of efficasy in treatment of solid tumors such as pancreatic, ovarian and colorectal cancers . In addition, "The Company is soon to meet with the MHRA (Medicines and Healthcare Products Regulatory Agency) to discuss formal preclinical and clinical development activities for PRP." In addition PPCH has announced they intend to apply for Orphan Drug designation in both the US and EU very soon.
By the volume we've seen, and are seeing, I'd say people are taking this quite seriously. HUGE potential!!